Protagonist Therapeutics PTGX Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's pre-tax income?
- Protagonist Therapeutics (PTGX) reported pre-tax income of $2.28M in Q1 2026.
- How has Protagonist Therapeutics's pre-tax income changed year-over-year?
- Protagonist Therapeutics's pre-tax income increased by 119.6% year-over-year, from -$11.66M to $2.28M.
- What is the long-term trend for Protagonist Therapeutics's pre-tax income?
- Over 3 years (2021 to 2025), Protagonist Therapeutics's pre-tax income has grown at a 1.0% compound annual growth rate (CAGR), from -$125.55M to -$129.31M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.